PLI Scheme for Pharmaceuticals – USPC Prelims

  • Aim: To enhance India’s manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in the pharmaceutical sector.
  • Under the scheme, manufacturers of pharmaceutical goods registered in India will be grouped based on their Global Manufacturing Revenue (GMR) to ensure wider applicability of the scheme across the pharmaceutical industry.
  • Duration of the Scheme: 2020-21 to 2028-29
Scroll to Top